Working Group on Prescription Drug Container Labels to Present Report to the U.S. Access Board on July 10, 2013

An advisory panel on access to prescription drug container labels will present its report at a meeting of the U.S. Access Board on July 10. The Working Group on Accessible Prescription Drug Container Labels will submit recommended best practices for making information on prescription drug container labels accessible to people who are visually impaired or who are elderly. This 18-member stakeholder panel, which was comprised of representatives from advocacy organizations and industry, explored various access alternatives, including braille, large print labels, and auditory technologies such as “talking bottles” and radio frequency identification tags. The working group’s recommendations are advisory only, not mandatory, and will not have the force of guidelines or standards. This guidance is being developed under the "Food and Drug Administration Safety and Innovation Act" which was signed into law last summer.

Meeting of the U.S. Access Board
July 10, 1:30 – 3:30
Access Board Conference Room
1331 F Street NW, Suite 800
Washington, DC 20004
Note: For the comfort of all participants and to promote a fragrance-free environment, attendees are requested not to use perfume, cologne, or other fragrances.

Call-in option (listening only):
Dial: (888) 790-2060 (toll-free)
Passcode: 6317703

Communication Access Real-time Translation (CART):
The web streaming link will be posted on the Board's website.

For the U.S. Access Board website: CLICK HERE